HomeAI · summaries
Storia in 9 fonti
FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy
A panel of advisers to FDA gave its endorsement to a seasonal mRNA flu vaccine that was developed by Moderna and that earlier this year became the subject of controversy.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
FDA staff scrutinizes evidence supporting Moderna’s flu vaccine
Ahead of a Thursday advisory panel meeting, agency scientists highlighted shortcomings in data accrued for a vaccine the FDA controversially refused to even review earlier this…
- ·
medpagetoday.com
FDA Staff Weighs In on Potential First mRNA Flu Shot
Moderna's novel vaccine was at the center of dustup with agency earlier this year
- ·
benzinga.com
FDA Panel Set To Debate Moderna Flu Shot - Moderna (NASDAQ:MRNA)
Moderna flu vaccine faces a key FDA advisory panel review as analysts weigh approval odds, postmarketing study costs, and growth potential.
- ·
Moderna flu vaccine wins unanimous support from FDA panel
The endorsement of an advisory committee positions Moderna to complete a dramatic turnaround for a shot the FDA declined to review earlier this year.
- ·
npr.org
Key FDA committee unanimously recommends its first vaccine since 2023
All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.
- ·
apnews.com
FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
U.S. health advisers are debating a new kind of flu vaccine. The new shot is made with the same mRNA technology that was key to ending the COVID-19 pandemic.
- ·
independent.co.uk
New mRNA flu vaccine faces scrutiny ahead of key FDA decision
U.S. health advisers are debating a new kind of flu vaccine
- ·
FDA Panel Endorses New Flu Shot That Uses Tech Dissed by RFK Jr.
Recommendation could pave the way for approval of the mRNA vaccine in adults 50 and up
- ·
statnews.com
FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy
A panel of advisers to FDA gave its endorsement to a seasonal mRNA flu vaccine that was developed by Moderna and that earlier this year became the subject of controversy.
- ·
nbcnews.com
FDA panel recommends Moderna’s mRNA flu shot for older adults
The vaccine was found to be about 27% more effective than the standard flu shot in a late-stage trial. The FDA and the CDC still must sign off on the vaccine before it’s available.
- ·
arstechnica.com
FDA advisors unanimously vote to approve Moderna's mRNA after agency drama
In February, a Trump official refused to review the vaccine.
- ·
Moderna's Flu Vaccine Clears Key FDA Panel Vote As Advisory Committee Backs Shot 9-0 - Moderna (NASDAQ:MR
Moderna’s experimental flu vaccine won unanimous FDA panel backing ahead of an Aug. 5 decision.